Bupropion normalizes cognitive performance in patients with depression
- PMID: 17435629
- PMCID: PMC1924979
Bupropion normalizes cognitive performance in patients with depression
Figures
Similar articles
-
Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.Psychiatry Res. 2008 Jul 15;160(1):72-82. doi: 10.1016/j.psychres.2007.04.012. Epub 2008 May 23. Psychiatry Res. 2008. PMID: 18501971
-
Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.Psychopharmacol Bull. 2003 Spring;37(2):67-78. Psychopharmacol Bull. 2003. PMID: 14566216 Clinical Trial.
-
Efficacy of bupropion XR in treatment-resistant elderly patients: a case series study.Clin Neuropharmacol. 2011 Jan-Feb;34(1):17-20. doi: 10.1097/WNF.0b013e3182096f5a. Clin Neuropharmacol. 2011. PMID: 21206361
-
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26. Psychiatry Res. 2009. PMID: 19709754 Clinical Trial.
-
Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.Pharmacopsychiatry. 2006 Jul;39(4):152-4. doi: 10.1055/s-2006-946706. Pharmacopsychiatry. 2006. PMID: 16871471
Cited by
-
Paying attention to attention in depression.Transl Psychiatry. 2019 Nov 7;9(1):279. doi: 10.1038/s41398-019-0616-1. Transl Psychiatry. 2019. PMID: 31699968 Free PMC article. Review.
-
Exploration of 100 commonly used drugs and supplements on cognition in older adults.Alzheimers Dement. 2013 Nov;9(6):724-32. doi: 10.1016/j.jalz.2012.12.002. Epub 2013 Aug 15. Alzheimers Dement. 2013. PMID: 23954027 Free PMC article.
-
Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.Can J Psychiatry. 2014 Dec;59(12):649-54. doi: 10.1177/070674371405901206. Can J Psychiatry. 2014. PMID: 25702365 Free PMC article. Review. No abstract available.
-
Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D3 in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression.Brain Sci. 2020 Aug 31;10(9):600. doi: 10.3390/brainsci10090600. Brain Sci. 2020. PMID: 32878267 Free PMC article. Review.
-
Cognitive remission: a novel objective for the treatment of major depression?BMC Med. 2016 Jan 22;14:9. doi: 10.1186/s12916-016-0560-3. BMC Med. 2016. PMID: 26801406 Free PMC article. Review.
References
-
- Gualtieri CT, Johnson LG, Benedict KB. Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci. 2006;18:217–225. - PubMed
-
- Jeste DV, Heaton SC, Paulsen JS, Ercoli L, Harris J, Heaton RK. Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. Am J Psychiatry. 1996;153:490–496. - PubMed
-
- Doraiswamy PM, Krishnan KR, Oxman T, et al. Does antidepressant therapy improve cognition in elderly depressed patients? J Gerontol A Biol Sci Med Sci. 2003;58:M1137–M1144. - PubMed
-
- Nebes RD, Pollock BG, Houck P, et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res. 2003;37:99–108. - PubMed
-
- Butters MA, Becker JT, Nebes RD, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000;157:1949–1954. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources